Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Scalp hair cortisol and testosterone levels in patients with sarcoidosis.

van Manen MJG, Wester VL, van Rossum EFC, van den Toorn LM, Dorst KY, de Rijke YB, Wijsenbeek MS.

PLoS One. 2019 Jun 14;14(6):e0215763. doi: 10.1371/journal.pone.0215763. eCollection 2019.

2.

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS.

Lung. 2018 Oct;196(5):569-575. doi: 10.1007/s00408-018-0144-4. Epub 2018 Aug 7.

3.

Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis.

Moor CC, van Manen MJG, Tak NC, van Noort E, Wijsenbeek MS.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702508. doi: 10.1183/13993003.02508-2017. Print 2018 Mar. No abstract available.

PMID:
29348156
4.

Clubbing in patients with fibrotic interstitial lung diseases.

van Manen MJG, Vermeer LC, Moor CC, Vrijenhoeff R, Grutters JC, Veltkamp M, Wijsenbeek MS.

Respir Med. 2017 Nov;132:226-231. doi: 10.1016/j.rmed.2017.10.021. Epub 2017 Nov 2.

PMID:
29229102
5.

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

van Manen MJG, Birring SS, Vancheri C, Vindigni V, Renzoni E, Russell AM, Wapenaar M, Cottin V, Wijsenbeek MS.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701157. doi: 10.1183/13993003.01157-2017. Print 2017 Oct. No abstract available.

6.

Patient and partner empowerment programme for idiopathic pulmonary fibrosis.

van Manen MJG, van 't Spijker A, Tak NC, Baars CT, Jongenotter SM, van Roon LR, Kraan J, Hoogsteden HC, Wijsenbeek MS.

Eur Respir J. 2017 Apr 26;49(4). pii: 1601596. doi: 10.1183/13993003.01596-2016. Print 2017 Apr. No abstract available.

7.

What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany.

van Manen MJ, Kreuter M, van den Blink B, Oltmanns U, Palmowski K, Brunnemer E, Hummler S, Tak NC, van den Toorn L, Miedema J, Hoogsteden HC, Wijsenbeek MS.

ERJ Open Res. 2017 Feb 14;3(1). pii: 00065-2016. doi: 10.1183/23120541.00065-2016. eCollection 2017 Jan.

8.

Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

van Manen MJ, Geelhoed JJ, Tak NC, Wijsenbeek MS.

Ther Adv Respir Dis. 2017 Mar;11(3):157-169. doi: 10.1177/1753465816686743. Epub 2017 Jan 1. Review. Erratum in: Ther Adv Respir Dis. 2017 Jun;11(6):245.

9.

Cough in idiopathic pulmonary fibrosis.

van Manen MJ, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, Wijsenbeek MS.

Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015. Review.

10.

Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population.

Van Manen MJ, Wapenaar M, Strookappe B, Drent M, Elfferich M, de Vries J, Gosker HR, Birring SS, Patel AS, van den Toorn L, van den Blink B, Boomars K, Hoitsma E, Wijsenbeek MS.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):75-82.

PMID:
27055839

Supplemental Content

Loading ...
Support Center